Bacitracin zinc 400 UNT / neomycin sulfate 3.5 mg / polymixin B sulfate 5000 UNT in 1 GM Topical Cream
RxNorm 283616

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 283616 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bacitracin zinc 400 UNT / neomycin sulfate 3.5 mg / polymixin B sulfate 5000 UNT in 1 GM Topical Cream.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Bacitracin 400 UNT/ML / neomycin 3.5 mg/ML / polymyxin B 5000 UNT/ML Topical Cream
Primary clinical definition
AUI:12338499
View
PSN
Bacitracin zinc 400 UNT / neomycin sulfate 3.5 mg / polymixin B sulfate 5000 UNT in 1 GM Topical Cream
AUI:12993948
View
SY
Bacitracin zinc 400 UNT / neomycin sulfate 3.5 mg / polymixin B sulfate 5000 UNT in 1 GM Topical Cream
AUI:12993949
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
Bacitracin 400 UNT/ML / neomycin 3.5 mg/ML / polymyxin B 5000 UNT/ML Topical Cream
(Atom ID: 12338499)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
bacitracin 400 UNT/ML / neomycin 3.5 MG/ML / polymyxin B 5000 UNT/ML Topical Cream
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
283616
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12338499
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
283616
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN ACTIVATED
09/30/2020
Date the RxNorm atom was reactivated
RXN AI
{316332} 7300
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{336467} 11417
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{336563} 388
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{316332} 7299
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{336467} 1291
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{336563} 8536
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
400 UNT/ML / 3.5 MG/ML / 5000 UNT/ML
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{316332} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{336467} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{336563} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Cream
The RxTerm dose form name for this drug
PSNPrescribable

Prescribable Name (PSN):
Bacitracin zinc 400 UNT / neomycin sulfate 3.5 mg / polymixin B sulfate 5000 UNT in 1 GM Topical Cream
(Atom ID: 12993948)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
bacitracin zinc 400 UNT / neomycin sulfate 3.5 MG / polymixin B sulfate 5000 UNT in 1 GM Topical Cream
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
283616
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12993948
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
283616
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Bacitracin zinc 400 UNT / neomycin sulfate 3.5 mg / polymixin B sulfate 5000 UNT in 1 GM Topical Cream
(Atom ID: 12993949)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
bacitracin zinc 400 UNT / neomycin sulfate 3.5 MG / polymixin B sulfate 5000 UNT in 1 GM Topical Cream
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
283616
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12993949
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
283616
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Neomycin, Polymyxin, and Bacitracin Topical


Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
[Learn More]


* Please review the disclaimer below.